Encouraging to see early clinical signals emerging in a space that has long been difficult to target.
Excited to see how this field continues to evolve
@OncLive@oncodaily
https://t.co/N4jL6Zx0kE
Clinicogenomic landscape and outcomes of metastatic colorectal cancer patients with pathogenic GNAS variants - @polanimd et al. #ASCO25 Abst 3572 https://t.co/SggYVYy6Jg @TempusAI#crcsm#PrecisionMedicine
Excited to present our research at #ASCOGI2025! We explored therapeutic challenges and outcomes in a unique biomarker-defined colorectal cancer population with GNAS mutations.
Stay tuned—as we continue to explore outcomes for this distinct group. @InovaSchar
Incredibly grateful to Drs. Pazdur, @drjennifergao, @timilpatel, @tmprowell, @SuparnaWedam for an inspiring day at the #FDA White Oak campus! Thank you for sharing your invaluable insights – an honor to learn from the best in oncology & regulatory science @ASCO FDA Fellows Day!
I am beyond thrilled to announce that I will be serving as the Chief Hematology Oncology Fellow at ISCI for the upcoming academic year! This role is an incredible opportunity, and I am eager to lead, learn, and make impactful contributions #Oncology#Leadership#InovaSchar#Meded